Skip to content
March 28, 2024

Equity.Guru

Investment information for the new generation

Search

United States Food and Drug Administration

Medexus Pharmaceuticals (MDP.V) announced that they’re making their Triamcinolone Hexacetonide (TH) Injectable Suspension, USP (20 mg/ml) available in the United States through the FDA’s CDER Drug Shortage program in…